Clinical trials
Phase 2 Lymphoproliferative Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 4 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 5 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Terminated | 13 |
| Active, not recruiting | 12 |
| Recruiting | 8 |
| Withdrawn | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 12 |
| Amgen Research (Munich) GmbH | 4 |
| Center for International Blood and Marrow Transplant Research | 2 |
| Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Mayo Clinic | 2 |
| Seagen Inc. | 2 |
| miRagen Therapeutics, Inc. | 2 |
| AbbVie | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoproliferative Disorders | 57 |
| Lymphoma | 23 |
| Lymphoma, Non-Hodgkin | 21 |
| Lymphatic Diseases | 16 |
| Immune System Diseases | 15 |
| Lymphoma, Large B-Cell, Diffuse | 15 |
| Immunoproliferative Disorders | 14 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 14 |
| Leukemia | 13 |
| Neoplasms | 13 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.